Old Web
English
Sign In
Acemap
>
Paper
>
98PImplications for UK practice of the use of durvalumab in stage III NSCLC
98PImplications for UK practice of the use of durvalumab in stage III NSCLC
2019
M.S. Iqbal
P. Atherton
C Macgregor
A Wieczorek
J. Singer
J Walther
F. Little
S. Harden
C. Peedell
A. Cyriac
S Chowdhury
M. Bayne
K. Yip
A. Britten
C Powell
J. Brock
S. K. Datta
T Sevitt
A Mehta
Alastair Greystoke
Keywords:
Stage III NSCLC
Medicine
General surgery
Durvalumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]